NEW YORK, Jan. 30 (GenomeWeb News) - The National Institutes of Health has issued a request for applications for projects focused on the development of new proteomics and glycomics research tools. The grant opportunity is open to US small businesses and individuals.
The FOA, said the NIH, has special interest in projects focused on "the unique needs of glycomics and clinical proteomics" and is "open to unconventional or alternative approaches."
The SBIR/STTR grants outlay up to $200,000 per year for up to for two years during phase I and up to $400,000 per year for up to four years during phase II.
Applications for funding open on March 1. The RFA expires on April 2. Additional details can be found here.